Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study (Q44475110)

3 December 2017

Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study (English)

1 reference

chronic renal insufficiency

3 December 2017

1 reference

5

Michiaki Kubo

1 reference

3 December 2017

6

Jun Hata

1 reference

3 December 2017

2

Toshiharu Ninomiya

1 reference

3 December 2017

4

Koji Yonemoto

1 reference

3 December 2017

9

Yutaka Kiyohara

1 reference

3 December 2017

3

Yasufumi Doi

1 reference

3 December 2017

8

Mitsuo Iida

1 reference

3 December 2017

1

Masaharu Nagata

1 reference

3 December 2017

7

Kazuhiko Tsuruya

1 reference

PubMed ID

20176610

3 December 2017

language of work or name

English

0 references

publication date

22 February 2010

1 reference

Nephrology Dialysis Transplantation

3 December 2017

1 reference

3 December 2017

25

1 reference

3 December 2017

8

1 reference

3 December 2017

2557-2564

1 reference

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

3 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Is chronic kidney disease a cardiovascular disease risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

High prevalence of chronic kidney disease in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Prevalence of chronic kidney disease in the Japanese general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

How can we achieve global equity in provision of renal replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Overview of regular dialysis treatment in Japan as of 31 December 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Albuminuria and chronic kidney disease in association with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Progression, remission, regression of chronic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Lowering blood pressure reduces renal events in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

Preventing microalbuminuria in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ062

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ062

1 reference

3 December 2017

1 reference

PubMed ID

20176610